Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1–Expressing Tumors Compared to Normal Murine Lymphoid TissueDanique Giesen, Martin Pool|Clinical Cancer Research|2020Cited by 49